Showing results (371-380 of 565) with videos related to

Sort By:
Pageof 57
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn's diseaseAntonino Andrea Blandino, Peter Caravan, Rocco Ricciardi, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Gastroenterology|September 14, 2004
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trialStephen B Hanauer, Burton I Korelitz, Paul Rutgeerts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2017
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical OutcomesBritt Christensen, Stephen B Hanauer, Jonathan Erlich, et al.
The American Journal of Gastroenterology|June 24, 2003
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammationSunanda V Kane, William J Sandborn, Paul A Rufo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2019
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative ColitisChristopher Ma, William J Sandborn, Geert R D'Haens, et al.
Inflammatory Bowel Diseases|August 6, 2008
Budesonide induction and maintenance therapy for Crohn's disease during pregnancyDawn B Beaulieu, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's diseaseDaniel J Stein, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2004
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's diseaseStephen B Hanauer, Carrie L Wagner, Mohan Bala, et al.
Gastroenterology|February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trialStephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
Pageof 57